1. Home
  2. PSTV vs ATCH Comparison

PSTV vs ATCH Comparison

Compare PSTV & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • ATCH
  • Stock Information
  • Founded
  • PSTV 1996
  • ATCH 2022
  • Country
  • PSTV United States
  • ATCH United States
  • Employees
  • PSTV N/A
  • ATCH N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • ATCH
  • Sector
  • PSTV Health Care
  • ATCH
  • Exchange
  • PSTV Nasdaq
  • ATCH Nasdaq
  • Market Cap
  • PSTV 12.2M
  • ATCH 3.4M
  • IPO Year
  • PSTV N/A
  • ATCH N/A
  • Fundamental
  • Price
  • PSTV $0.62
  • ATCH $0.33
  • Analyst Decision
  • PSTV Strong Buy
  • ATCH
  • Analyst Count
  • PSTV 3
  • ATCH 0
  • Target Price
  • PSTV $12.75
  • ATCH N/A
  • AVG Volume (30 Days)
  • PSTV 3.6M
  • ATCH 1.0M
  • Earning Date
  • PSTV 05-19-2025
  • ATCH 05-27-2025
  • Dividend Yield
  • PSTV N/A
  • ATCH N/A
  • EPS Growth
  • PSTV N/A
  • ATCH N/A
  • EPS
  • PSTV N/A
  • ATCH 2.67
  • Revenue
  • PSTV $5,824,000.00
  • ATCH N/A
  • Revenue This Year
  • PSTV $13.26
  • ATCH N/A
  • Revenue Next Year
  • PSTV $8.84
  • ATCH N/A
  • P/E Ratio
  • PSTV N/A
  • ATCH $0.11
  • Revenue Growth
  • PSTV 18.54
  • ATCH N/A
  • 52 Week Low
  • PSTV $0.24
  • ATCH $0.28
  • 52 Week High
  • PSTV $2.67
  • ATCH $84.00
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 43.68
  • ATCH 29.83
  • Support Level
  • PSTV $0.49
  • ATCH $0.28
  • Resistance Level
  • PSTV $0.90
  • ATCH $0.60
  • Average True Range (ATR)
  • PSTV 0.13
  • ATCH 0.04
  • MACD
  • PSTV -0.01
  • ATCH 0.04
  • Stochastic Oscillator
  • PSTV 17.81
  • ATCH 24.21

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About ATCH AtlasClear Holdings Inc. Common Stock

AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and innovative financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.

Share on Social Networks: